Jun 18, 2026 06:45AM
Jun 18, 2026 06:45AM
Jun 12, 2026 04:10PM
Jun 12, 2026 04:10PM
Jun 8, 2026 04:35PM
Jun 8, 2026 04:35PM
Jun 8, 2026 04:30PM Merck and Gilead discontinue lung cancer drug combination trial
Jun 8, 2026 04:30PM
Jun 3, 2026 09:00AM
May 29, 2026 06:49AM
May 29, 2026 06:45AM
May 22, 2026 07:55AM
May 22, 2026 07:55AM
May 13, 2026 08:30AM Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
May 12, 2026 06:45AM
May 12, 2026 06:45AM
May 7, 2026 08:00AM
May 5, 2026 08:45AM
May 5, 2026 08:45AM
Apr 30, 2026 06:30AM
Apr 21, 2026 02:11PM FDA approves Merck's IDVYNSO for HIV-1 treatment switch
Apr 21, 2026 02:11PM
Apr 21, 2026 08:37AM
Apr 21, 2026 06:45AM
Apr 21, 2026 06:45AM
Apr 20, 2026 09:51AM
Apr 20, 2026 06:48AM
Apr 20, 2026 06:48AM FDA Grants Priority Review for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), for Cisplatin-Eligible Pat
Apr 17, 2026 07:50AM
Apr 17, 2026 07:49AM
Apr 13, 2026 07:01AM
Apr 13, 2026 07:00AM
Apr 2, 2026 06:45AM
Apr 2, 2026 06:45AM
Mar 30, 2026 11:45AM Merck drug shows superior cholesterol reduction in phase 3 trial
Mar 30, 2026 11:45AM
Mar 29, 2026 11:45AM
Mar 29, 2026 11:45AM
Mar 25, 2026 07:39AM
Mar 25, 2026 07:02AM
Mar 25, 2026 06:45AM
Mar 25, 2026 06:45AM Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)
Mar 18, 2026 04:30PM
Mar 18, 2026 04:30PM
Mar 17, 2026 06:50AM
Mar 17, 2026 06:50AM
Mar 16, 2026 08:00AM
Mar 16, 2026 08:00AM
Mar 4, 2026 08:00AM NeOnc Technologies sets phase 2 dose for brain cancer drug NEO212
Mar 4, 2026 08:00AM

323,879 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All